| KINGDOM: MONERA |
|
| BACTERIA |
DISEASES |
| Bartonella spp. |
Carrion’s Disease, Trench
Fever, Cat Scratch Disease, Bacillary Angiomatosis, Endocarditis |
| Borrelia burgdorferi |
Lyme Disease |
| Chlamydia trachomatis*** |
Urethritis, Cervicitis, Pelvic
Inflammatory Disease |
| Clostridium difficile*** |
Pseudomembranous colitis |
| Ehrlichia spp. |
Ehrlichiosis |
| Escherichia coli
O157:H7 |
Hemorrhagic colitis;
Thrombocytopenia; Hemolytic uremic syndrome |
| Non-O157 Shiga toxin-producing
Escherichia coli (STEC) |
Same as above |
| Helicobacter pylori |
Peptic Ulcer Disease, Gastric
Cancer and Gastric Lymphoma |
| Legionella pneumophila*** |
Legionnaire’s Disease |
| Listeria monocytogenes*** |
Listeriosis |
| Mycobacterium tuberculosis |
Tuberculosis |
| Nontuberculosis mycobacteria,
including: Mycobacterium avium complex
Mycobacterium genavense
Mycobacterium ulcerans |
Tuberculosis-like disease
Wasting Disease
Buruli Ulcer |
| Neisseria meningitidis |
Epidemic meningitis |
| Streptococcus pyogenes
(Group A streptococci) |
Severe Invasive Group A
Streptococcal Disease; Necrotizing fasciitis, Toxic shock syndrome |
| Vibrio cholerae |
Cholera |
| Vibrio parahaemolyticus
*** |
Gastroenteritis |
| Vibrio vulnificus*** |
Cellulitis; fatal bacteremia |
| Yersinia pestis |
Plague |
| *** = These emerging
pathogens are not featured prominently in the books on reserve in the Life Science
Library. Check with the librarian to see if other books about these important emerging
pathogens are available. |
|
| A. ANTIBIOTIC RESISTANCE IN:
|
|
| THE HOSPITAL (NOSOCOMIAL
INFECTIONS) |
|
| Enterobacter cloacae
and Klebsiella Pneumoniae (ESBL) |
Resistance to
"extended-spectrum B Lactamases" (ESBL) |
| Pseudomonas aeruginosa |
Aminoglycoside resistance |
| Enterococcus spp. (VRE) |
Vancomycin-resistant
enterococci (VRE) |
| Staphylococcus aureus
(MRSA) |
Methicillin (or multiply drug)
resistant Stapylococcus aureus) (MRSA) |
| Staphylococcus aureus
(VISA/ GISA) |
S. aureus that show
high level resistance to methicillin plus intermediate resistance to vancomycin:
Vancomycin Intermediate Resistant S. aureus (VISA) or Glycopeptide Intermediate
Resistant S. aureus (GISA) |
| THE COMMUNITY |
|
| Streptococcus pneumoniae |
Resistance to penicillin and
other antibiotics |
| Neisseria gonorrhoeae*** |
Resistance to quinolones |
| Mycobacterium tuberculosis |
Multi-drug resistance |
| THE FARM |
|
| Salmonella typhimurium
DT104 |
Gastroenteritis |
| Campylobacter jejuni |
Campylobacteriosis, enteritis |
| B. EMERGING INFECTIONS
IN THE NEWLY INDEPENDENT STATES OF THE FORMER SOVIET UNION: |
|
| Corynebacterium diptheriae |
Epidemic Diptheria |
| Treponema pallidum *** |
Epidemic Syphilis |
| KINGDOM: PROTISTA |
|
| PROTOZOA |
DISEASES |
| Babesia microti |
Babesiosis |
| Cryptosporidium spp. |
Cryptosporidiosis |
| Cyclospora spp. |
Enteritis |
| Giardia lamblia
(G.duodenalis) |
Giardiasis |
| Isospora belli |
Enteritis |
| Microsporidia |
Microsporidiosis |
| Plasmodium spp.
(resistance to antimalarial drugs) |
Malaria |
| AMOEBAE |
|
| Naegleria fowleri |
Primary Amebic
Meningoencephalitis |
| Acanthamoeba spp. |
Granulomatous Amebic
Encephalitis (GAE) and Acanthamoeba Keratitis |
| ALGAE |
|
| Pfiesteria piscicida*** -"The
Cell from Hell" |
Pain, narcosis,
disorientation, nausea, fatigue, vomiting, memory loss, immune failure and personality
changes |
| KINGDOM : FUNGI |
|
| YEASTS |
|
| Azole–resistant Candida
albicans |
Candidiasis |
| Azole-resistant non-albicans Candida
spp. |
Disseminated infections in
immunocompromised hosts |
| Trichosporon beigelii |
(same as above) |
| Cryptococcus neoformans |
Cryptococcosis |
| MOLDS |
|
| Fusarium spp. (hyaline
molds) |
Fusariosis |
| Zygomycetes (hyaline molds) |
Zygomycosis |
| Pseudallescheria boydii
(dematiaceous mold) |
Mycetomas, pneumonias, and
disseminated infections |
| Scedosporium prolificans
(dematiaceous Mold) |
Disseminated infections in
immunocompromised hosts |
| DIMORPHIC FUNGI |
|
| Coccidioides immitis |
Coccidioidomycosis |
| Histoplasma capsulatum |
Histoplasmosis |
| Penicillium marneffei |
Penicilliosis |
| VIRUSES: |
DISEASES |
| Arenaviruses: Guanarito
virus
Junin virus
Lassa virus
Machupo
Sabia virus |
Venezuelan hemorrhagic
fever
Argentine hemorrhagic fever
Lassa fever
Bolivian hemorrhagic fever
Brazilian hemorrhagic fever |
| Bunyaviruses: Crimean-Congo
hemorrhagic fever virus
Rift Valley fever virus
Hantaviruses, including:
Hantaan virus
Sin Nombre virus |
Crimean Congo hemorrhagic
fever
Rift Valley fever
Korean hemorrhagic fever
Hantavirus Pulmonary Syndrome |
| Cytomegalovirus |
Congenital and perinatal
infections; severe disease in immunocompromised hosts |
| Flaviviruses: Dengue
virus
Yellow fever virus |
Dengue hemorrhagic fever,
dengue shock syndrome
Yellow fever |
| Equine morbillivirus virus |
Fatal, systemic disease in
horses and humans |
| Filoviruses: Ebola
virus
Marburg virus |
Ebola hemorrhagic fever
Marburg hemorrhagic fever |
| Genital Papillomavirus |
Genital and nongenital warts;
cervical cancers and other malignant genital tumors |
| Hepatitis Viruses: Hepatitis
A (Picornavirus)
Hepatitis B (Hepadnavirus)
Hepatitis C (Flavivirus)
Hepatitis D (Deltavirus)
Hepatitis E (Calcivirus) |
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatitis E |
| Herpes simplex viruses type 1
and 2 (HSV-1 and HSV-2) (resistance to acyclovir) |
Gingivostomatitis, Herpes
genitalis, perinatal disseminated diseae |
| VIRUSES
(con’t): |
DISEASES |
| Human herpesvirus 6 (HHV-6)*** |
Exanthem subitum (sixth
disease or roseola infantum) |
| Human herpesvirus 8 (HHV-8) |
Karposi’s Sarcoma |
| Human immunodeficiency
viruses: (HIV-1 and HIV-2) (multi-drug resistant) |
Acquired Immunodeficiency
Syndrome |
| Human T-cell lymphotropic
viruses (HTLV-I and HTLV II)*** |
Leukemias and lymphoma |
| Influenza viruses |
Influenza |
| Rabies virus |
Rabies |
| Venezuelan equine encephalitis
viruses |
Encephalitis |
| PRIONS: |
New-variant Creutzfeldt-Jakob
disease (transmissible spongiform encephalopathy in humans) *** |